Folic acid supplementation in postmenopausal women with hot flushes: Phase III randomised double-blind placebo-controlled trial
AuthorsEwies, A. A. A.
Barraclough, Lisa H
AffiliationSandwell and West, Birmingham Hospitals NHS Trust, Birmingham, UK.
MetadataShow full item record
AbstractObjective: To assess whether folic acid supplementation ameliorates hot flushes. Design: Double-blind, placebo-controlled randomised trial. Setting: Nine hospitals in England. Population: Postmenopausal women experiencing ≥50 hot flushes weekly. Methods: Women (n = 164) were randomly assigned in a 1:1 ratio to receive folic acid 5 mg tablet or placebo daily for 12 weeks. Participants recorded frequency and severity of hot flushes in a Sloan Diary daily and completed Greene Climacteric and Utian Quality of Life (UQoL) Scales at 4-week intervals. Main outcome measures: The change in daily Hot Flush Score at week 12 from randomisation based on Sloan Diary Composite Score B calculation. Results: Data of 143 (87%) women were available for the primary outcome. The mean change (SD) in Hot Flush Score at week 12 was -6.98 (10.30) and -4.57 (9.46) for folic acid and placebo group, respectively. The difference between groups in the mean change was -2.41 (95% CI -5.68 to 0.87) (P = 0.149) and in the adjusted mean change -2.61 (95% CI -5.72 to 0.49) (P = 0.098). Analysis of secondary outcomes indicated an increased benefit in the folic acid group regarding changes in total and emotional UQoL scores at week 8 when compared with placebo. The difference in the mean change from baseline was 5.22 (95% CI 1.16-9.28) and 1.88 (95% CI 0.23-3.52) for total and emotional score, respectively. Conclusions: The study was not able to demonstrate that folic acid had a statistically significant greater benefit in reducing Hot Flush Score over 12 weeks in postmenopausal women when compared with placebo.
CitationEwies A, Ahmed I, Al-Azzawi F, Pitkin J, Gupta P, Persic M, et al. Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double-blind placebo-controlled trial. BJOG: Int J Obstet Gy. 2021 Jun 8.
JournalBJOG-an International Journal of Obstetrics and Gynaecology
- Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial.
- Authors: Reddy SY, Warner H, Guttuso T Jr, Messing S, DiGrazio W, Thornburg L, Guzick DS
- Issue date: 2006 Jul
- Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo.
- Authors: van de Weijer PH, Barentsen R
- Issue date: 2002 Jul 25
- Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women.
- Authors: Yu H, Racketa J, Chines AA, Mirkin S
- Issue date: 2013 Apr
- Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical data.
- Authors: Constantine GD, Archer DF, Pollycove R, Jiang W, Altomare C, Pinkerton JV
- Issue date: 2016 Sep
- Folic acid supplementation cures hot flushes in postmenopausal women.
- Authors: Gaweesh S, Ewies AA
- Issue date: 2010 Feb